Multiple government agencies are scrutinizing the use of ethylene oxide (EtO) to sterilize medical devices. EPA has proposed closing EtO facilities due to concerns that emissions from the sites could harm the health of surrounding communities. FDA has been working with orthopedic manufacturers to reduce the amount of EtO used to sterilize medical devices, and has pushed for innovation in the space. This panel discussion updates efforts to limit the use of EtO and advises on new sterilization technologies. The experts will detail the challenges and opportunities associated with switching sterilization methods and ways that orthopedic companies can do it effectively.
• Understand government agencies’ current thinking on EtO
• Grasp the pros and cons of alternative sterilization methods
• Know how validation, regulatory and infrastructure requirements impact sterilization methods